证券研究报告行业周度点评医疗器械集采规则不断完善，板块政策面持续向好2023年12月04日重点股票2022A2023E2024E评级评级领先大市EPS（元）PE（倍）EPS（元）PE（倍）EPS（元）PE（倍）买入买入迈瑞医疗7.9236.689.7629.7611.5925.06增持增持评级变动：维持心脉医疗4.9641.736.5631.558.5524.21增持增持惠泰医疗5.3770.347.3751.259.9238.08增持增持行业涨跌幅比较鱼跃医疗1.5921.252.3614.322.2215.22医疗器械沪深300我武生物0.6744.150.7638.920.9531.142023-032023-062023-092023-1218%澳华内镜0.16412.060.65101.431.0463.398%-2%开立医疗0.8659.991.1544.861.5134.17-12%-22%海泰新光2.128.141.5637.882.1128.002022-12资料来源：iFinD，财信证券%1M3M12M投资要点：医疗器械行情回顾：上周医药生物（申万）...